MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
99 100 Next >
Valvoline Inc (NYSE:VVV) Q2 Beats Estimates, Lifts Full-Year Outlook ↗
Via Chartmill
Tickers VVV
Installed Building Products (NYSE:IBP) Shares Tumble 10.6% After Q1 2026 Earnings Miss Amid Housing Headwinds ↗
Via Chartmill
Topics Earnings
Tickers IBP
Exposures Financial
Chicago Atlantic Real Estate Finance (NASDAQ:REFI) Revenue Misses Estimates, EPS Beats in Q1 2026 Results ↗
Via Chartmill
Tickers REFI
ZURA BIO LTD (NASDAQ:ZURA) Q1 2026: Cash Runway Extended Through 2028 as Phase 2 Trials Advance ↗
Via Chartmill
Tickers ZURA
N-able (NYSE:NABL) Shares Slip After Q1 Results, But Full-Year Outlook Holds the Line ↗
Via Chartmill
Tickers NABL
Xometry (NASDAQ:XMTR) Crushes Q1 Estimates, Raises Guidance, and Secures Strategic Partnership with Siemens ↗
Via Chartmill
Tickers XMTR
Lexicon Pharmaceuticals (NASDAQ:LXRX) Q1 2026 Results Show Revenue Beat and Narrowed Loss ↗
Via Chartmill
Tickers LXRX
Stratasys Ltd (NASDAQ:SSYS) Q1 2026 Results: Revenue Miss But Defense Demand Drives Optimism ↗
Via Chartmill
Tickers SSYS
NCDL (Nuveen Churchill Direct Lending Corp.) Shares Edge Higher Despite Slight Q1 2026 Earnings Miss on Lower Portfolio Yields ↗
Via Chartmill
Topics Earnings
Tickers NCDL
Exposures Financial
Rapport Therapeutics (NASDAQ:RAPP) Beats Q1 Estimates, Guided by Strong Seizure Data and Accelerated Timelines ↗
Via Chartmill
Tickers RAPP
Broadridge Financial Solutions (NYSE:BR) Passes the Caviar Cruise Quality Screen with Strong Profitability and Cash Flow ↗
Via Chartmill
Tickers BR
Kelly Services (NASDAQ:KELYA) Revenue and EPS Miss Estimates in Q1 Results ↗
Via Chartmill
Tickers KELYA
Suburban Propane Partners LP (NYSE:SPH) Fiscal Q2 Earnings Beat Expectations Despite Revenue Miss ↗
Via Chartmill
Topics Earnings
Tickers SPH
Exposures Financial
Real Brokerage (NASDAQ:REAX) Beats Q1 EPS Estimates, Posts 32% Revenue Jump Amid Landmark RE/MAX Acquisition ↗
Via Chartmill
Tickers REAX
Which stocks are moving before the opening bell on Thursday? ↗
Via Chartmill
Tickers AAON AGL ASBP ATRA CCRN ENGN
GPGI (NYSE:GPGI) Plunges 12.7% Pre-Market After Q1 Earnings Miss ↗
Via Chartmill
Tickers GPGI
OppFi Inc (NYSE:OPFI) Q1 Earnings Beat Drives 165% Net Income Surge ↗
Via Chartmill
Topics Earnings
Tickers OPFI
Exposures Financial
Harmony Biosciences Holdings (NASDAQ:HRMY) Q1 Revenue Meets Guidance, But EPS Miss and Elevated Spending Weigh on Shares ↗
Via Chartmill
Tickers HRMY
Ironwood Pharmaceuticals (NASDAQ:IRWD) Crushes Q1 Estimates with 97% LINZESS Surge ↗
Via Chartmill
Tickers IRWD
Gibraltar Industries Inc (NASDAQ:ROCK) Q1 Earnings Beat Revenue Estimates but Miss on EPS Amid Profitability Pressure ↗
Via Chartmill
Topics Earnings
Tickers ROCK
Exposures Financial
Insmed (NASDAQ:INSM) Q1 Revenue Miss Triggers Pre-Market Slide Despite Narrower Loss ↗
Via Chartmill
Tickers INSM
Ligand Pharmaceuticals (NASDAQ:LGND) Shares Fall on Q1 Revenue and EPS Miss ↗
Via Chartmill
Tickers LGND
Nexstar Media Group (NASDAQ:NXST) Surges on Q1 Earnings Beat Driven by Record Revenue and TEGNA Acquisition ↗
Via Chartmill
Topics Earnings
Tickers NXST
Exposures Financial
Viatris (NASDAQ:VTRS) Shares Rise as Q1 Earnings Top Estimates ↗
Via Chartmill
Tickers VTRS
ARKO Corp. (NASDAQ:ARKO) Surges on Q1 Earnings Beat, Fueled by Margin Expansion and Strategic Progress ↗
Via Chartmill
Topics Earnings
Tickers ARKO
Exposures Financial
Xeris Biopharma (NASDAQ:XERS) Achieves First Profit, Beats Q1 Estimates with 95% Recorlev Surge ↗
Via Chartmill
Tickers XERS
Scholar Rock (SRRK) Q1 Loss Narrows In Line Awaits PDUFA Decision ↗
Via Chartmill
Tickers SRRK
Liberty Latin America (NASDAQ:LILA) Q1 2026 Results Miss Estimates, Unveils Preferred Stock Distribution ↗
Via Chartmill
Tickers LILA
WHF (WhiteHorse Finance Inc) Shares Dip 3% Pre-Market After Q1 Earnings and Revenue Miss ↗
Via Chartmill
Tickers WHF
Iovance Biotherapeutics (NASDAQ:IOVA) Reports Q1 Revenue Beat and Raised Guidance, Yet Stock Slips Pre-Market ↗
Via Chartmill
Tickers IOVA
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story